The Avian Influenza (AI) virus strain H9N9 has been seen more often and keeps spreading. The University of Minnesota conducted a research trying to determine the Stalosan F efficacy against this particular virus. The product has been tested already against highly pathogenic avian influenza virus H5N1 and the study indicated excellent results.
This research performed by UM is the second test demonstrating that Stalosan F is effective against one more type of AI virus - H9N9.
Stalosan product manager, DVM Ivan Gospodinov explains: “Speaking from a biosecurity standpoint Stalosan F is the only product in this category with documented efficacy against two different AI viruses - H5N1 and H9N9. As a manufacturer of this product, we are proud to announce the second test and the excellent results that Stalosan F achieved.’’
The test conducted in association with University of Minnesota was performed in triplicate and with four different contact times - between 5 minutes and 6 hours. All four contact intervals in the triplicate study revealed almost the same efficacy of Stalosan F against the tested organism.
Ivan Gospodinov continues, “The results once again illustrated that Stalosan F stands firm in its category and why it is often imitated – but never duplicated”.
Mentioned in this news release: